The Association between ESR and CRP and Systemic Hypertension in Sarcoidosis

Mehdi Mirsaeidi, Hesham R. Omar, Golnaz Ebrahimi, Micheal Campos

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Introduction. The association between the level of systemic inflammation and systemic hypertension (sHTN) among subjects with sarcoidosis has not been previously explored. Methods. A retrospective study was conducted to investigate the relation between the level of systemic inflammation in sarcoidosis, measured by various serum inflammatory markers, and sHTN. Results. Among a total of 108 cases with sarcoidosis (mean age: 53.4 years, 76.9% females), 55 (50.9%) had sHTN and 53 (49.1%) were normotensive. ESR was highly associated with sHTN. The patients with sHTN had higher mean ESR levels compared with normotensives (48.8 ± 35 versus 23.2 ± 27 mm/hr, resp.; P = 0.001). ROC curve analysis for ESR revealed an AUC value of 0.795 (95% CI: 0.692-0.897; P = 0.0001). With regard to CRP, there was a trend towards higher mean values in sHTN group (3.4 versus 1.7 mg/L; P = 0.067) and significantly higher prevalence of sHTN in the highest CRP quartile compared to the lowest one (69.6% versus 30%; OR 4.95; P = 0.017). ROC curve analysis for CRP revealed an AUC value of 0.644 (95% CI: 0.518-0.769; P = 0.03). On multivariate analysis, ESR and the CRP remained independent predictors for sHTN among subjects with sarcoidosis. Conclusion. Systemic inflammation is associated with the presence of sHTN in sarcoidosis.

Original languageEnglish (US)
Article number2402515
JournalInternational Journal of Hypertension
Volume2016
DOIs
StatePublished - 2016

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'The Association between ESR and CRP and Systemic Hypertension in Sarcoidosis'. Together they form a unique fingerprint.

  • Cite this